Drug
Icp 189
Icp 189: highest development phase Phase 1, developed by InnoCare Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- InnoCare Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ICP-189 NCT05370755 | Phase 1 | Patients With Advanced Solid Tumors |
Latest
No recent events.
Follow Icp 189 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.